Gray Wealth Management Inc. Sells 35 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Gray Wealth Management Inc. trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.6% in the 4th quarter, Holdings Channel.com reports. The firm owned 733 shares of the healthcare conglomerate’s stock after selling 35 shares during the period. Gray Wealth Management Inc.’s holdings in UnitedHealth Group were worth $386,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of UNH. Kraft Davis & Associates LLC raised its stake in shares of UnitedHealth Group by 3.4% in the third quarter. Kraft Davis & Associates LLC now owns 577 shares of the healthcare conglomerate’s stock worth $294,000 after purchasing an additional 19 shares during the last quarter. Iron Horse Wealth Management LLC lifted its stake in UnitedHealth Group by 1.6% during the 3rd quarter. Iron Horse Wealth Management LLC now owns 1,217 shares of the healthcare conglomerate’s stock valued at $614,000 after acquiring an additional 19 shares during the period. Secure Asset Management LLC raised its holdings in shares of UnitedHealth Group by 0.8% during the third quarter. Secure Asset Management LLC now owns 2,456 shares of the healthcare conglomerate’s stock valued at $1,238,000 after purchasing an additional 19 shares during the last quarter. Bensler LLC boosted its holdings in UnitedHealth Group by 0.3% in the third quarter. Bensler LLC now owns 7,293 shares of the healthcare conglomerate’s stock worth $3,677,000 after purchasing an additional 19 shares during the last quarter. Finally, Texas Capital Bancshares Inc TX raised its stake in UnitedHealth Group by 1.1% during the 3rd quarter. Texas Capital Bancshares Inc TX now owns 1,695 shares of the healthcare conglomerate’s stock valued at $855,000 after buying an additional 19 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analysts Set New Price Targets

A number of analysts recently commented on the company. Bank of America reiterated a “buy” rating and set a $675.00 price objective on shares of UnitedHealth Group in a research report on Thursday, March 7th. Oppenheimer reissued an “outperform” rating and issued a $610.00 price objective on shares of UnitedHealth Group in a report on Wednesday, January 17th. TD Cowen decreased their price target on shares of UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating on the stock in a research report on Wednesday, April 10th. Royal Bank of Canada reduced their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday. Finally, Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price target on shares of UnitedHealth Group in a report on Wednesday, April 10th. Three analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $569.68.

View Our Latest Report on UNH

Insider Activity at UnitedHealth Group

In other news, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now directly owns 32,289 shares in the company, valued at approximately $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the completion of the transaction, the executive vice president now owns 9,364 shares in the company, valued at $4,527,306.72. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Thomas E. Roos sold 858 shares of the business’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. 0.35% of the stock is owned by insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock traded up $14.19 on Thursday, hitting $493.18. 8,871,197 shares of the company traded hands, compared to its average volume of 4,525,480. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. The business has a 50-day simple moving average of $489.51 and a 200 day simple moving average of $515.38. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $554.70. The stock has a market capitalization of $454.68 billion, a P/E ratio of 30.38, a price-to-earnings-growth ratio of 1.28 and a beta of 0.54.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue was up 8.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $6.26 EPS. Research analysts expect that UnitedHealth Group Incorporated will post 27.75 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 dividend on an annualized basis and a dividend yield of 1.52%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.